VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - May 25, 2007) - WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX:WXI) today announces that the Company has reconstituted its Scientific Advisory Board and appointed an outstanding group of physicians and scientists to its new Scientific Advisory Board. These five advisory board members will provide WEX senior management with scientific and medical advice on the Company's drug development plans and strategies.